Greeting
酒井/Sakai
西川/Nishikawa
Sakai Greeting

3D human organ engineering for implantation and cell-based assay
”Optimization of 3D organization and mass transfer”

Prof. Sakai

General goal and approaches of our lab

The general goal of our lab is the 3D organization of cultured organ/tissue-derived cells such as liver or pancreas cells in various scales for regenerative medicine and cell-based assay for drug or chemical screenings without having to resort to animal testing. In our body,

  1. Cells are hierarchically organized at a very high cell density
  2. The vascular system consistently supplies nutrients and removes waste/metabolites, thus attaining very high per-volume-based functionality.

However, full arrangement of such vascular systems in vitro is a challenging task to achieve due to the complexity of to simultaneously optimizing 3D high-density cellular organization and mass transfer between the cells and flow channels.

The most important step is to overcome the conflicting issues in various scales required by relevant applications. I believe academic knowledge of chemical engineering will give the basis for the optimization. For example, if we intend to organize large tissue equivalents for implantation therapy, the tissue should at least be arranged with a 3D branching/joining flow channel network as in vivo vasculature and the channels should be perfused with suitable culture medium containing oxygen carriers. Also, in order to make a small tissue for cell-based assays, we have to organize the cells to create an environment that the cells reorganize as their original tissues. At the same time, we need to pay special attention to mass transfers between the cells and the incubation medium, so that various kinetic parameters concerning metabolism are the same as those obtained in vivo. Chemical engineering undeniably gives a firm basis not only for analysis/description of these issues but also for further optimization and designing the suitable tissue-based devices/systems in various scales.

In order to realize cultured cell-based therapy or assays, we need to integrate knowledge and technologies from various disciplines in a well-balanced manner; that is, basic biology of growth, differentiation and maturation of human stem cells or organ progenitors, advanced engineering such as micropatterning, microfluidics, microfabrication or biomaterials, and medical or pharmaceutical knowledge about diseases and responses against therapy or administration of drugs. Due to the increasing complexity and versatility of current science and engineering, it is difficult to integrate the necessary technologies in one laboratory. We are therefore actively organizing and participating in collaborations with various research groups. To efficiently perform such objective-oriented integration, we use the objective-oriented frame of mind of chemical engineering. For example, we first set a final goal, then layout all the necessary knowledge and technologies with appropriate time points, and finally we implement the research and development along the roadmap. By doing this, the time for achieving the goal is minimized and even if some novel but unanticipated innovation emerges in related areas, we can judge the feasibility of relevant innovation. Even for regenerative medicine and development of cell-based assays, setting our basis on the chemical engineering discipline is important. Indeed, cell-culture related chemical engineering encompasses the basic biological findings and their applications via advanced engineering technologies.

Current scope of our lab

When engineers do research on human body systems, there are three typical approaches: from metabolism/biochemistry (the target is endoderm-derived organs), mechanics (mesoderm-derived organs) and informatics (ectoderm-derived organs). Because our main concerns are transport/metabolism-related aspect of the human body, our tentative targets are liver, pancreas or kidney for regenerative medicine and small intestine, lung, liver or kidney for cell-based assays. The typical research approach is as follows; first, design tissues in terms of cell-to-cell interaction and mass transfer according to the requirements of the relevant application, then culture stem/progenitor cells, and finally complete the devices/systems using advanced engineering technologies.

Message to future lab members

We welcome students or researches who have interest in 3D organ engineering. Since our lab participates in education and research at graduate levels (both master and doctoral courses), we seek motivated students not only from Tokyo University but also other universities all over the world. We also welcome postdoctoral researchers according to the financial situation. If you are interested in our lab, feel free to contact me (sakaiyasu[at]chemsys.t.u-tokyo.ac.jp) or Dr. Nishikawa (masaki[at]chemsys.t.u-tokyo.ac.jp), the research associate of our lab, and visit our lab. We can accept students from two departments in the Graduate School of Engineering; the Department of Chemical System Engineering and the Department of Bioengineering. Although there are no obvious differences in the thesis research, the curriculums are completely different, so please choose your department carefully.

Because we focus on the best integration of knowledge and technologies toward the final goal, I ask lab members to adopt an objective-oriented way of thinking and to constantly acquire knowledge about biosystems. Once you adopt such an attitude, you do not have to be afraid even if you happen to hold a completely different position in the future.

Positions held since graduation

  • Sep 2015- Professor, Departent of Chemical System Engineering, Graduate School of Engineering, University of Tokyo
  • Apr 2013- March 2016 Director, International Research Cemter on Integrative Biomedical Systems (CIBiS), IIS, University of Tokyo
  • >Nov 2008- Professor at IIS, University of Tokyo (Organs and Biosystems Engineering Lab.)
  • Nov 2003 to Oct 2008 Associate Professor at the Center for Disease Biology and Integrative Medicine (CDBIM),
    Graduate School of Medicine, University of Tokyo (Regenerative Medical Engineering Lab.)
  • Sep 2001- Oct 2008 Associate Professor at IIS, University of Tokyo (Organs and Biosystems Lab.)
  • Jul 1998- August, 1998 Lecturer at IIS, University of Tokyo
    (Environmental Chemical Engineering Lab. organized by Prof. M. Suzuki)
  • May 1997- April 1998 Visiting Scientist at the Department of Chemical Engineering, University of Rochester
    (Host was Prof. J. H. David Wu)
  • May 1990- Research Associate at IIS, University of Tokyo
    (Environmental Chemical Engineering Lab. organized by Prof. M. Suzuki)

Education

  • Doctor of Philosophy, University of Tokyo (1993). Major, Chemical Engineering;
    Thesis title, Study on the control of morphology and functional expression of anchorage-dependent mammalian cells.
  • Master of Engineering, University of Tokyo (1989). Major, Chemical Engineering;
    Thesis title, Kinetic study on the attachment and spreading of cultured mammalian cells.
  • Bachelor of Engineering, University of Tokyo (1987). Major, Chemical Engineering;
    Thesis title, Study on the secretion mechanism of alpha-hemolysin in E. coli cells.

Scientific awards

  • January, 2009: Publication award for 2008, FANUC FA and Robot Foundation Toshiki NIINO, Hiromichi NARUKE, Shunsuke OIZUMI, Yasuyuki Sakai, Hongyun HUANG (Institute of Industrial Science) fabrication of three-dimensional scaffolds for regeneration of high-metabolic-rate organs by selective laser sintering using water soluble leachable filler - Fabrication of porous bodies with fine flow channel network from biodegradable plastic - (Journal of the Japan Society for Precision Engineering, (73(11), 1246-1250, 2007) FANUC FA and Robot Foundation
  • December, 2006: Paper award of the Japanese Society for Alternatives to Animal Experiments, Development of a toxicity evaluation system for gaseous compounds using air-liquid interface culture of a human bronchial epithelial cell line, Calu-3, AATEX, 11, 59-67 (2005).
  • September, 2001: Publication Award of the Society for Bioscience and Bioengineering, Japan, Rapid and sensitive neurotoxicity test based on the morphological changes of PC12 cells with simple computer-assisted image analysis (J. Biosci. Bioneg., 90(1), 20-24 (2000)).
  • September, 1996: Young Investigators Award of the Society of Chemical Engineers, Japan, Large-scale preparation of porcine hepatocyte spheroids and their immobilization for bioartificial liver systems.

Professional activities

  • April 2022 - Fellow, Society for Chemical Engineers, Japan
  • June 2020 - “Frontiers in Toxicology” Editorial Board
  • July 2020 - Guest Professor, Technological University of Compiegne, France.
  • March 2020 - Feb 2022 Chair, Division of Biotechnology, Society for Chemical Engineers, Japan (SCEJ)
  • 2019 -, Editorial Board, “Bio-Design and Manufacturing”.
  • Feb 2019 - Associate Editor, “Bio-Design and Manufacturing”.
  • Jan 2017 - Dec 2021, President, Japanese Society for Alternatives to Animal Experiments (JSAAE)
  • Jan 2014 - Dec 2019, Executive Board Member, Japanese Society for Artificial Organs (JSAO)
  • Feb 2012- Academic Fellow, American Institute for Medical and Biological Engineering (AIMBE)
  • Jan 2001 - Japanese Society of Alternatives to Animal Experiments (JSAAE), administrator officer, vice president, chair of PR committee, chair of planning, permanent editorial board of AATEX journal, Chair of PR committee, WC6-2006 in Tokyo (World Congress on Alternatives and Animal Use for Life Sciences) etc.
  • April 2000 - Japanese Society of Artificial Organs (JSAO), Councilor, member of Information and PR committee, member of selection of councilors, member of future planning etc.
  • Oct 2004 - Society for Chemical Engineers, Japan (SCEJ), Member and chair of Medical Group, Division of Biotechnology, Organizing member of Kanto Branch, etc.
  • Oct 2006 - Japanese Society of Regenerative Medicine, Councilor
  • April 2007 - March 2010 Member of the technical roadmap committee (Risk evaluation and management of chemicals), Ministry of Economy, Trade and Industry (METI), Japan.
  • April 2005 - March 2007 Japanese Society of Therapeutic Engineering, Editorial Board of the Society Journal
  • Oct 1998 - May 2003 Japanese Society of Water Environment, member of the committee for planning, organizing member of Kanto Branch etc.
西川昌輝 挨拶

Assoc. prof. Nishikawa


We take responsibility for cultivating the soil (education) and creating a thick trunk (research).

We foster a virtuous cycle in which big flowers (research results) create good soil (personnel).

I hope that all lab members will spend their lives nurturing a large tree and making it bloom into a big flower.


Research

    Understanding, controlling, and reconstructing living organisms from both hardware and software perspectives
    ― Engineering answers to the question, “What is life?” ―

    Hardware
    Regenerative medicine: tissue and organ reconstruction

    We aim to reconstruct transplantable organs in vitro. We are working to construct instant cells, tissues and organs using special techniques. We are also attempting to construct renal organoids from cultured progenitor cells and to introduce blood vessels in vitro.

    Software
    Drug Discovery and Therapy: Modeling of living organisms (in vitro and in silico models))

    We aim to establish efficient and scientifically rational drug discovery and treatments for various diseases by modeling living organisms.
    We are working on the construction of culture models focusing on organs such as the liver, kidney, and intestine that determine the disposition of drugs in the body. We are also working on the construction of mechanism-based mathematical models for metabolic reaction, cell, organ, and organism-levels, to understand multi-level phenomena.
    In particular, we focus on diseases such as lifestyle-related diseases, aging, and cancer, as well as energy metabolism, which is directly related to life phenomena themselves. We aim to suppress and treat diseases at the biological level by integrating data obtained from culture models with mathematical models.


Education

    The Individuals We Aim for
  • Individuals who have a lifelong desire to learn, grow, and take on challenges
  • Individuals who can discover and set issues on their own and solve them logically and persistently

  • Point of focus

  • Knowledge and logic
  • Analogical thinking
  • Unique point of view
  • Motivation
  • Cooperativeness
  • Based the perspectives above, we quantify the growth and educational effects of each member, including myself, to clarify and improve issues.


Positions held since graduation

  • 22024 Associate Professor, Department of Chemical Systems Engineering, Graduate School of Engineering, University of Tokyo (Sakai-Nishikawa Laboratory)
  • 2019 Lecturer, Department of Chemical Systems Engineering, Graduate School of Engineering, University of Tokyo (Sakai-Nishikawa Laboratory)
  • 2012 Assistant Researcher, UCLA David Geffen School of Medicine GLAVAHS at Sepulveda
  • 2008 Research Scientist, UCLA David Geffen School of Medicine GLAVAHS at Sepulveda

Education

  • 2008 Doctor of Philosophy, Department of Chemical Systems Engineering, Graduate School of Engineering, University of Tokyo (Yasuyuki Sakai Laboratory)
  • 2005 Master of Engineering, Department of Chemical Systems Engineering, Graduate School of Engineering, University of Tokyo (Sakai Laboratory)
  • 2003 Bachelor of Engineering, Department of Chemical Systems Engineering, The University of Tokyo (Takeo Yamaguchi Laboratory)
  • 2001 University of Tokyo, School of Engineering, Department of Chemical Systems Engineering
  • 1999 University of Tokyo, Faculty of Liberal Arts, Department of Chemistry
  • 1999 Graduated from Todaiji Gakuen High School

Professional activities

  • Society of Chemical Engineers, Japan, General Secretary (FY2020-), Delegate (FY2024-)
  • Society for Alternatives to Animal Experiments, Delegate (FY2021-), Member of General Affairs (FY 2019-2021), Vice Chair of General Affairs (FY 2022-), Chair of Public Relations Committee (FY 2023-)
  • Society for Regenerative Medicine, U45 Working Group (FY2021-)
  • The Society for Artificial Organs, Secretary General of the 61st Congress (FY2023-)
  • The Society for Hepatocyte Research, Secretary General of the 31st Hepatocyte Research Meeting (FY2024-)